Clinical trial

Safety and Efficacy of Neoadjuvant Radiochemotherapy in Adenocarcinoma of the…

NCT00374985 · Johannes Gutenberg University Mainz, Other · Completed

Key facts

NCT number NCT00374985
Title Safety and Efficacy of Neoadjuvant Radiochemotherapy in Adenocarcinoma of the Gastric-oesophageal Junction
Official title Prospective, Open, Multicentre Phase I/II Study to Evaluate the Safety and Efficacy of a Neoadjuvant Radiochemotherapy With Docetaxel and Oxalipaltin in Patients With Adenocarcinoma of the Gastric-oesophageal Junction
Lead sponsor Johannes Gutenberg University Mainz, Other
Status Completed
Phase Phase 1/Phase 2
Study type Interventional
Conditions Esophageal Neoplasms, Stomach Neoplasms
Intervention type Drug, Procedure
Interventions Docetaxel, Oxaliplatin, Radiotherapy
Enrollment 25
Start date Oct 1, 2005
Primary completion Sep 1, 2013
Completion Sep 1, 2013
First posted Sep 12, 2006
Last update posted Dec 2, 2014
Countries Germany

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies